Tag: grant
-
MIT, IBM Open Artificial Intelligence Lab
Massachusetts Institute of Technology and IBM are establishing a joint lab to advance the state of knowledge and business impact of artificial intelligence.
-
Engineered Insulin-Producing Cells to Be Grown in Lab
A team from three universities is developing in the lab synthetic islet cells, the cells that produce insulin in the pancreas, for eventual transplantation in people with type 1 diabetes.
-
Study Testing Repurposed Drugs with Resistant Bacteria
A university team is investigating two current drug compounds for their ability to take on a new task, fighting bacteria becoming resistant to antibiotics.
-
Small Business Grant Funds Blood-Brain Barrier Model
A spin-off company from University of Washington is developing a chip device emulating the blood-brain barrier that prevents many drugs from treating neurological disorders.
-
Trial Underway Testing New ALS Treatment
Patients in a clinical trial testing a treatment for amyotrophic lateral sclerosis, or ALS, began receiving their first doses administered by the study team.
-
System Designed to Monitor Bee Colony Health Buzz
A system being developed by a Canadian graduate student monitors the health of bee colonies by analyzing the sounds they make in the hive.
-
Synthetic Beating Heart Repair Tissue Being Developed
A bioengineering team is developing a synthetic patch that contracts and sends electrical signals to repair heart muscle tissue after a heart attack.
-
Engineered Viruses Studied to Improve Plant Traits.
A research study funded by the U.S. Department of Defense is investigating genetic alterations of plant viruses for delivery of genes to quickly protect corn crops against threats like pests and drought.
-
Calif. Agency Supporting Late Stem Cell Trial for ALS
California’s agency supporting stem cell research for regenerative medicine is helping fund a clinical trial testing stem cell treatments for amyotrophic lateral sclerosis, or ALS.
-
Grant Funding Automated Genome Editing System
A consortium of companies and university in the U.K. and U.S. are developing an automated desktop genome editing system using the emerging Crispr technique.